2,073
Views
1
CrossRef citations to date
0
Altmetric
Neurology

Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes

, , , , , & show all
Pages 512-513 | Received 23 Dec 2020, Accepted 05 Mar 2021, Published online: 23 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.